ACRO Biomedical Co., Ltd. (TPEX:6748)

Market Cap	5.31B +127.5%
Revenue (ttm)	38.26M -13.5%
Net Income	-82.66M
EPS	-1.35
Shares Out	71.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	886,940
Open	76.30
Previous Close	75.40
Day's Range	73.60 - 78.90
52-Week Range	33.85 - 94.30
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About ACRO Biomedical

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. The company was founded in 2014 and is based in Kaohsiung, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 34
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6748

Financial Performance

In 2025, ACRO Biomedical's revenue was 38.26 million, a decrease of -13.51% compared to the previous year's 44.23 million. Losses were -82.66 million, 33.1% more than in 2024.